Compile Data Set for Download or QSAR
maximum 50k data
Found 79 with Last Name = 'buynitsky' and Initial = 'js'
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083766(2-(3,5-Dichloro-biphenyl-4-sulfonylamino)-3-({5-[4...)
Affinity DataIC50:  4.60nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083788(2-(2-Chloro-6-methyl-benzenesulfonylamino)-3-({5-[...)
Affinity DataIC50:  7.10nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083789(2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({5-[4...)
Affinity DataIC50:  8.80nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083768((S)3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dih...)
Affinity DataIC50:  10.6nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083768((S)3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dih...)
Affinity DataIC50:  10.6nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083769(3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50:  15nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083783(2-(2,6-Dichloro-benzenesulfonylamino)-3-({5-[4-(1H...)
Affinity DataIC50:  18nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083791(3-({5-[3-(6-Amino-pyridin-2-yl)-propyl]-4,5-dihydr...)
Affinity DataIC50:  26nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083785(3-({5-[3-(1H-Imidazol-2-ylcarbamoyl)-propyl]-4,5-d...)
Affinity DataIC50:  31nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083775(3-[(5-{2-[3-(1H-Imidazol-2-yl)-ureido]-ethyl}-4,5-...)
Affinity DataIC50:  34nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083780(2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({5-[4...)
Affinity DataIC50:  44nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083770(3-({5-[3-(2-Amino-1H-imidazol-4-yl)-propyl]-4,5-di...)
Affinity DataIC50:  46nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083767(3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50:  51nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083781(3-({5-[4-(Pyridin-2-ylamino)-butyl]-4,5-dihydro-is...)
Affinity DataIC50:  54nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083774(3-({5-[4-(4,5-Dihydro-1H-imidazol-2-ylamino)-butyl...)
Affinity DataIC50:  62nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083771(2-(3,5-Dimethyl-isoxazole-4-sulfonylamino)-3-({5-[...)
Affinity DataIC50:  73nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083786(2-Benzenesulfonylamino-3-({5-[4-(pyridin-2-ylamino...)
Affinity DataIC50:  81nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083765(3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50:  106nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083773(2-(Biphenyl-4-sulfonylamino)-3-({5-[4-(pyridin-2-y...)
Affinity DataIC50:  130nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50055900(3-{2-[(R)-3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  140nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083784(2-(Naphthalene-1-sulfonylamino)-3-({5-[4-(pyridin-...)
Affinity DataIC50:  160nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076575(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  160nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50076575(3-{5-[4-amino(imino)methylaminobutyl]-4,5-dihydro-...)
Affinity DataIC50:  169nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083792(2-(4-Isopropyl-benzenesulfonylamino)-3-({5-[4-(pyr...)
Affinity DataIC50:  170nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083770(3-({5-[3-(2-Amino-1H-imidazol-4-yl)-propyl]-4,5-di...)
Affinity DataIC50:  180nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083783(2-(2,6-Dichloro-benzenesulfonylamino)-3-({5-[4-(1H...)
Affinity DataIC50:  190nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083778(2-(Biphenyl-4-sulfonylamino)-3-({5-[4-(1H-imidazol...)
Affinity DataIC50:  240nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50055900(3-{2-[(R)-3-(4-Carbamimidoyl-phenyl)-4,5-dihydro-i...)
Affinity DataIC50:  240nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083770(3-({5-[3-(2-Amino-1H-imidazol-4-yl)-propyl]-4,5-di...)
Affinity DataIC50:  280nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083783(2-(2,6-Dichloro-benzenesulfonylamino)-3-({5-[4-(1H...)
Affinity DataIC50:  350nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083788(2-(2-Chloro-6-methyl-benzenesulfonylamino)-3-({5-[...)
Affinity DataIC50:  390nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083767(3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50:  570nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083774(3-({5-[4-(4,5-Dihydro-1H-imidazol-2-ylamino)-butyl...)
Affinity DataIC50:  600nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083774(3-({5-[4-(4,5-Dihydro-1H-imidazol-2-ylamino)-butyl...)
Affinity DataIC50:  690nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083789(2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({5-[4...)
Affinity DataIC50:  690nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083769(3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50:  850nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083768((S)3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dih...)
Affinity DataIC50:  890nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083768((S)3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dih...)
Affinity DataIC50:  930nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083768((S)3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dih...)
Affinity DataIC50:  980nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083787(2-Amino-3-({5-[4-(1H-imidazol-2-ylamino)-butyl]-4,...)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083779(3-({5-[4-(Isoquinolin-1-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083782(2-[2,4,6-trimethylphenylsulfonylamino]-3-[5-(4-ami...)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083790(2-(2,4,6-Trimethyl-benzenesulfonylamino)-3-{[5-(4-...)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083777(3-({5-[4-(Isoquinolin-3-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083771(2-(3,5-Dimethyl-isoxazole-4-sulfonylamino)-3-({5-[...)
Affinity DataIC50:  1.50E+3nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083766(2-(3,5-Dichloro-biphenyl-4-sulfonylamino)-3-({5-[4...)
Affinity DataIC50:  1.60E+3nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50408869(CHEMBL2111850)
Affinity DataIC50:  2.80E+3nMAssay Description:Inhibition of vitronectin receptor (alpha V beta 3), expressed on human 293 cells, binding to immobilized fibrinogenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083765(3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of platelet aggregation in human gel-purified platelets containing fibrinogen (GPP+Fg).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083789(2-(3,5-Dimethyl-biphenyl-4-sulfonylamino)-3-({5-[4...)
Affinity DataIC50:  3.10E+3nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Dupont Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50083765(3-({5-[4-(1H-Imidazol-2-ylamino)-butyl]-4,5-dihydr...)
Affinity DataIC50:  4.70E+3nMAssay Description:Inhibition of platelet aggregation in human platelet rich plasma (PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 79 total ) | Next | Last >>
Jump to: